Hypertonic sodium lactate

DRUG2 trials

Sponsors

Innogene Kalbiotech Pte. Ltd

Conditions

Coronary Heart DiseaseDengue Shock Syndrome

Phase 3

Effect of Hypertonic Sodium Lactate on sVCAM-1 Level as Surrogate Marker of Endothelial Capillary Leakage in Pediatric Dengue Shock Syndrome Patients (DSS)

Innogene Kalbiotech Pte. LtdDengue Shock Syndrome

Start: 2008-05-31End: 2009-12-31Updated: 2009-08-28

Phase 4

Efficacy and Safety of Hypertonic Sodium Lactate Solution Compared With 6% HES Solution in CABG Patients

CompletedNCT01654653

Innogene Kalbiotech Pte. LtdCoronary Heart Disease

Start: 2008-07-31End: 2009-03-31Updated: 2012-08-01

Related Papers

Early resuscitation of dengue shock syndrome in children with hyperosmolar sodium-lactate: a randomized single-blind clinical trial of efficacy and safety.

2014-09-0530 citations